Plasmapp플라즈맵
405000 · KOSDAQ · ₩405000 · 플라즈맵
- Market cap
- ₩20B
- Enterprise value
- ₩30B
- P/E
- —
- P/B
- 15.2×
- Dividend yield
- 0.0%
- ROE
- −589.6%
- Net margin
- −64.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−59.6% from the high
₩3,030Today: ₩3,515 – ₩3,790₩9,200
Returns
- 1W−4.6%
- 1M−0.3%
- 3M−21.0%
- 6M−51.6%
- YTD−35.9%
- 1Y−54.2%
- Volume today
- 3,562
- 0.3× the 20-day average
- Traded today
- ₩13M
- Listed shares
- 5,373,532
- EPS (12 months)
- −₩1,438
- Earnings yield −38.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
+5.8% on Oct 27, 2026.
- • Foreign investors sold a net ₩1.3M that day
We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.
Possible reasons, not certainties. Not financial advice.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat-0.1% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Plasmapp stock overview
Plasmapp (플라즈맵, KRX: 405000) is listed on KOSDAQ, in the Medical & precision devices sector. The company is a plasma technology firm founded in 2015 as a spin-off from a KAIST physics laboratory, commercializing its bio plasma technology in the global medical device market and expanding into healthcare. Its shares closed at ₩3,715 on Oct 27, 2026, up 5.84% on the day, giving it a market value of ₩20B.
Key facts
- Market cap
- ₩20B
- Sector
- Medical & precision devices
- Latest price change
- +5.84%
- As of
- Oct 27, 2026
- Main business
- The company is a plasma technology firm founded in 2015 as a spin-off from a KAIST physics laboratory, commercializing its bio plasma technology in the global medical device market and expanding into healthcare.
Quick answers about Plasmapp
- What does Plasmapp do?
- The company is a plasma technology firm founded in 2015 as a spin-off from a KAIST physics laboratory, commercializing its bio plasma technology in the global medical device market and expanding into healthcare. Its main products are the STERLINK plasma sterilizers for surgical devices, the ACTILINK plasma surface activators for dental and orthopedic implants, and the PLASMA ENDO system for periodontal and root canal treatment, with sterilizer sales also building a base for high-margin consumables such as sterilant packs. Its products are sold to hospitals, specialty clinics, and implant dentists in markets including Korea, Europe, the United States, Japan, and Asia.
- What is the market cap of Plasmapp?
- The market capitalisation of Plasmapp was ₩20B at the close on Oct 27, 2026.
- Who are the largest shareholders of Plasmapp?
- According to the latest official filings, the largest reported holders are Dreamtech (67.87%, as of Oct 2, 2026); Kiwoom Securities (4.86%, as of Jul 24, 2026); LB Investment (3.91%, as of Sep 22, 2025).
- When is the next earnings report from Plasmapp?
- Korean companies rarely announce results dates in advance. Based on when Plasmapp filed the same report in past years, its next 3q results is expected between Oct 31, 2026 and Nov 14, 2026.
Company profile
The company is a plasma technology firm founded in 2015 as a spin-off from a KAIST physics laboratory, commercializing its bio plasma technology in the global medical device market and expanding into healthcare. Its main products are the STERLINK plasma sterilizers for surgical devices, the ACTILINK plasma surface activators for dental and orthopedic implants, and the PLASMA ENDO system for periodontal and root canal treatment, with sterilizer sales also building a base for high-margin consumables such as sterilant packs. Its products are sold to hospitals, specialty clinics, and implant dentists in markets including Korea, Europe, the United States, Japan, and Asia.
Written by AI from the company's latest annual report.
- Korean name
- 플라즈맵
- Themes
- Medical devices
- CEO
- 이윤철(단독 대표이사)
- Founded
- Mar 2015
- Listed
- Oct 2022
- Listed shares
- 5,373,532
- Fiscal year ends
- Month 12
- Website
- plasmapp.com/
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- 5%+ holding reportOct 2, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment)Jul 31, 2026
- 5%+ holding reportJul 31, 2026
- Insider shareholding reportJul 31, 2026
Titles in Korean until English translations are added.
Also known as: Plasmapp / 플라즈맵 / 405000 / KRX:405000
Source: KRX statistical information